MRIMath

MRIMath is a medical technology company based in Birmingham, Alabama, founded in 2017. The company specializes in artificial intelligence solutions for brain tumor analysis, focusing on glioblastoma segmentation and volumetric measurement. Their flagship product, MRIMath i2Contour, is an FDA-cleared tool that enhances the efficiency and accuracy of brain tumor mapping and measurement. This platform allows physicians to perform tumor and organs-at-risk segmentation and volumetric analysis quickly and accurately through a secure cloud-based system. MRIMath aims to improve medical decision-making by providing reliable AI and machine learning tools that enhance patient outcomes and physician satisfaction. The company values innovation, customer focus, and high standards, creating a supportive workplace environment. Their primary customers include neuro-oncologists, radiologists, and other medical professionals involved in brain tumor diagnosis and treatment, with endorsements from leading institutions highlighting the platform's accuracy and usability.

• Employees24
• Founded2019